Market Tracker

11/27 1:05pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

0.60
Data as of Nov 26
 -0.01 / -1.64%
Today’s Change
0.45
Today|||52-Week Range
7.10
-90.12%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close0.61
Today’s open0.60
Day’s range0.59 - 0.62
Volume275,934
Average volume (3 months)664,313
Market cap$21.5M
Dividend yield--
Data as of 3:59pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
--RepliCel Life Scienc...-0.07-17.88%
CBLICleveland Biolabs In...-0.00-1.11%
PRPHProPhase Labs Inc+0.02+1.43%
REPHRecro Pharma Inc0.000.00%
Data as of 3:59pm ET, 11/26/2014

Financials

Last reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts